Status:
UNKNOWN
Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions:
Breast Cancer
Eligibility:
FEMALE
16+ years
Brief Summary
The purpose of this study is to collect clinical data, blood samples, and self reported symptoms of peripheral neuropathy from Chinese patients with breast cancer after treatment with taxanes. This da...
Eligibility Criteria
Inclusion
- Diagnosis of breast cancer
- Females aged 16 and older
- Planning to receive or previous treated with taxanes
Exclusion
- Poorly controlled or insulin-dependent diabetes or other condition likely to predispose to neurotoxicity
Key Trial Info
Start Date :
August 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04068090
Start Date
August 23 2019
End Date
December 1 2020
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China, 100021